AT
AGN

Arvest Trust’s Allergan plc AGN Stock Holding History

Arvest Trust’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$26.4M Buy
118,226
+352
+0.3% +$72.9K 2.44% 7
2014
Q1 		$24.1M Sell
117,874
-1,376
-1% -$273K 2.32% 7
2013
Q4 		$20M Sell
119,250
-3,070
-3% -$480K 1.99% 10
2013
Q3 		$17.7M Buy
+122,320
New +$16.3M 1.93% 12

Other funds holding AGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
IIS
Ignis Investment Services Edinburgh, United Kingdom $29.9B AUM

Arvest Trust's AGN Position: Q2 2014 in Review

Arvest Trust increased its Allergan plc (AGN) stake by 0.3% in Q2 2014, buying an estimated $72.9K and bringing the position to 118,226 shares worth $26.4M. The position accounts for 2.44% of the portfolio, ranked #7.

Arvest Trust first reported a position in AGN in Q3 2013 and has held it in 4 quarters since. 674 funds tracked by Wall St. Rank hold AGN as of Q2 2014.

  • Arvest Trust held 118,226 shares of Allergan plc worth $26.4M as of Q2 2014.
  • Arvest Trust bought 352 Allergan plc shares in Q2 2014, an estimated $72.9K.
  • Allergan plc made up 2.44% of Arvest Trust's portfolio in Q2 2014, its #7 holding.
  • Arvest Trust first reported a position in Allergan plc in Q3 2013 and has held it in 4 quarters since.
  • 674 funds tracked by Wall St. Rank held Allergan plc as of Q2 2014.

Based on Arvest Trust's 13F filing for Q2 2014, filed 14 Jul 2014.